- Latest available (Revised)
- Original (As made)
This is the original version (as it was originally made).
1.—(1) This Order may be cited as the Medicines and Healthcare Products Regulatory Agency Trading Fund Order 2003 and shall come into force on 1st April 2003.
(2) In this Order—
“the 1968 Act” means the Medicines Act 1968(1);
“the fund” means the fund established by Article 2 of this Order;
“funded operations” means the operations described in Schedule 1 to this Order;
“reference substance” means a chemical or biological reference preparation used in tests or assays in connection with or related to the production of medicinal products or similar products; and
“tissue bank” means any place where human tissue or cells are stored or processed.
(3) In this Order expressions defined in the 1968 Act, the Medicines for Human Use (Marketing Authorisations Etc.) Regulations 1994(2), or the Medical Devices Regulations 2002(3) for the purposes of that Act or those Regulations shall have the same meaning as is given for the purposes of that Act or those Regulations.
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: